01:15 AM EDT, 07/21/2026 (MT Newswires) -- Bio-Gate (BIG1.F) will launch a private placement and a rights offering of up to 407,747 new shares, respectively, for 2.8 euros apiece, according to a Monday release. Gross proceeds of up to 1.1 million euros from the private placement are earmarked for short-term investments. The rights offering is scheduled from July 30 through Aug. 13, and its gross proceeds of up to 1.1 million euros will be used to enhance the company's financial flexibility for further investments. The German antimicrobial and antiviral technology company will also reduce its share capital through the consolidation of five shares into one. The new shares are expected to be listed on the Munich Stock Exchange's open market segment by Aug. 26.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.